Kiniksa Pharmaceuticals International, plc KNSA Change in Other Assets
Change in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Kiniksa Pharmaceuticals International, plc in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherNoncurrentAssets.
The official record: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kiniksa Pharmaceuticals International, plc's change in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kiniksa Pharmaceuticals International, plc's change in other assets?
- Kiniksa Pharmaceuticals International, plc (KNSA) reported change in other assets of -$125K in Q1 2026.
- How has Kiniksa Pharmaceuticals International, plc's change in other assets changed year-over-year?
- Kiniksa Pharmaceuticals International, plc's change in other assets increased by 93.9% year-over-year, from -$2.05M to -$125K.
- What is the long-term trend for Kiniksa Pharmaceuticals International, plc's change in other assets?
- Over 2 years (2021 to 2024), Kiniksa Pharmaceuticals International, plc's change in other assets has grown at a 72.2% compound annual growth rate (CAGR), from $3.28M to $9.74M.
- What does change in other assets mean?
- Change in miscellaneous assets affecting operating cash flow.